دورية أكاديمية
أعرض في EDS

Cancer of the Liver and its Relationship with Diabetes mellitus.

التفاصيل البيبلوغرافية
العنوان: Cancer of the Liver and its Relationship with Diabetes mellitus.
المؤلفون: Onikanni SA; Department of Chemical Sciences, Biochemistry Unit, 470822Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria.; College of Medicine, Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan., Lawal B; PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, 38032Taipei Medical University and Academia Sinica, Taipei.; Graduate Institute for Cancer Biology & Drug Discovery, College of Medical Science and Technology, 38032Taipei Medical University, Taipei., Bakare OS; Department of Biochemistry, 107994Adekunle Ajasin University, Akungba Akoko, Ondo State, Nigeria., Ajiboye BO; Phytomedicine and Molecular Toxicology Research Laboratory, Department of Biochemistry, Federal University Oye-Ekiti, Ekiti State, Nigeria., Ojo OA; Phytomedicine, Molecular Toxicology, and Computational Biochemistry Research Laboratory (PMTCB-RL), Department of Biochemistry, Bowen University, Iwo, 232101, Nigeria., Farasani A; Biomedical Research Unit, Medical Research Center, College of Applied Medical Sciences, 123285Jazan University, Jazan, Saudi Arabia.; Department of Medical Laboratory Technology, College of Applied Medical Sciences, 123285Jazan University, Jazan, Saudi Arabia., Kabrah SM; Department of Laboratory Medicine Faculty of Applied medical sciences, 48058Umm Al-Qura University, Kingdom of Saudi Arabia., Batiha GE; Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, 289643Damanhour University, Damanhour, AlBeheira, Egypt., Conte-Junior CA; Analytical and Molecular Laboratorial Center (CLAn), Institute of Chemistry (IQ), Federal University of Rio de Janeiro (UFRJ), Cidade Universitária, Rio de Janeiro, RJ, 21941-909, Brazil.
المصدر: Technology in cancer research & treatment [Technol Cancer Res Treat] 2022 Jan-Dec; Vol. 21, pp. 15330338221119743.
نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: SAGE Country of Publication: United States NLM ID: 101140941 Publication Model: Print Cited Medium: Internet ISSN: 1533-0338 (Electronic) Linking ISSN: 15330338 NLM ISO Abbreviation: Technol Cancer Res Treat Subsets: MEDLINE
أسماء مطبوعة: Publication: 2015-: Thousand Oaks, CA : SAGE
Original Publication: Schenectady, NY : Adenine Press, c2002-
مواضيع طبية MeSH: Non-alcoholic Fatty Liver Disease*/complications , Non-alcoholic Fatty Liver Disease*/therapy , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/therapy , Liver Neoplasms*/complications, Humans ; Liver Cirrhosis/complications
مستخلص: A high increase witnessed in type II diabetes mellitus (T2DM) globally has increasingly posed a serious threat to global increases in liver cancer with the association between diabetes mellitus type II and the survival rate in liver cancer patients showing unstable findings. An increase in the development and progression of chronic liver disease from diabetes mellitus patients may be connected to cancer of the liver with several links such as Hepatitis B and C virus and heavy consumption of alcohol. The link between T2DM patients and liver cancer is centered on non-alcoholic fatty liver disease (NAFLD) which could be a serious threat globally if not clinically addressed. Several reports identified metformin treatment as linked to a lower risk of liver cancer prognosis while insulin treatment or sulphonylureas posed a serious threat. Mechanistically, the biological linkage between diabetes type II mellitus and liver cancer are still complex to understand with only the existence of a relationship between NAFLD and high level of energy intake and diabetes mellitus induces hepatic damage, increased liver weight thereby causes multiple pro-inflammatory cytokines that lead to the development of liver cancer. Therefore, this review gives an account of the pathophysiological importance of liver cancer position with T2DM, with the role of NAFLD as an important factor that bridges them.
References: Gastroenterology. 2002 Nov;123(5):1705-25. (PMID: 12404245)
Mol Genet Metab. 1998 Oct;65(2):121-8. (PMID: 9787104)
Diabetes Care. 2011 Mar;34(3):616-21. (PMID: 21273499)
Cells. 2021 Oct 25;10(11):. (PMID: 34831096)
Gastroenterology. 2004 Feb;126(2):460-8. (PMID: 14762783)
Science. 2013 Sep 6;341(6150):1241214. (PMID: 24009397)
Front Pharmacol. 2021 Aug 27;12:691234. (PMID: 34512327)
Nat Rev Clin Oncol. 2017 Feb;14(2):85-99. (PMID: 27502359)
Biochem J. 2015 Mar 1;466(2):203-18. (PMID: 25697093)
Biomedicines. 2021 Oct 30;9(11):. (PMID: 34829812)
Clin Liver Dis. 2011 May;15(2):223-43, vii-x. (PMID: 21689610)
Cell Death Differ. 2019 Dec;26(12):2710-2726. (PMID: 30988397)
World J Gastroenterol. 2013 Nov 7;19(41):6969-78. (PMID: 24222941)
Diabetologia. 2013 Sep;56(9):1944-8. (PMID: 23722623)
Aging (Albany NY). 2019 Sep 13;11(17):7197-7205. (PMID: 31518336)
Diabetes Res Clin Pract. 2014 Feb;103(2):137-49. (PMID: 24630390)
Hepatology. 2002 Nov;36(5):1206-13. (PMID: 12395331)
Hepatology. 2006 Dec;44(6):1408-10. (PMID: 17133479)
Biomed Res Int. 2022 Apr 20;2022:4122166. (PMID: 35496049)
Nat Rev Microbiol. 2013 Sep;11(9):639-47. (PMID: 23912213)
Diabetes Res Clin Pract. 2020 Feb;160:108025. (PMID: 31954752)
Popul Health Metr. 2015 Dec 05;13:33. (PMID: 26640415)
Hepatobiliary Surg Nutr. 2016 Oct;5(5):433-437. (PMID: 27826559)
Int J Mol Sci. 2016 May 20;17(5):. (PMID: 27213358)
Cancer Cell. 2008 Aug 12;14(2):156-65. (PMID: 18691550)
Gastroenterology. 2001 Apr;120(5):1183-92. (PMID: 11266382)
Hepatology. 2016 Jul;64(1):73-84. (PMID: 26707365)
Cancer Biol Med. 2016 Dec;13(4):407-425. (PMID: 28154773)
Clin Liver Dis. 2015 May;19(2):361-79. (PMID: 25921668)
Am J Gastroenterol. 2001 Aug;96(8):2462-7. (PMID: 11513191)
Hepatology. 2002 Jul;36(1):227-42. (PMID: 12085369)
J Hepatol. 2014 Jul;61(1):75-81. (PMID: 24607626)
J Hepatol. 2013 Feb;58(2):385-7. (PMID: 22940407)
Oncotarget. 2017 Jun 16;8(39):65397-65406. (PMID: 29029439)
Oncotarget. 2017 Jun 08;8(58):97862-97870. (PMID: 29228657)
Semin Liver Dis. 2001;21(1):17-26. (PMID: 11296693)
Comput Struct Biotechnol J. 2021 Sep 02;19:4970-4983. (PMID: 34584637)
Curr Diab Rep. 2017 Apr;17(4):20. (PMID: 28290049)
Cancers (Basel). 2020 May 26;12(6):. (PMID: 32466400)
Diabetes Care. 2007 Mar;30(3):734-43. (PMID: 17327353)
Arch Biochem Biophys. 2000 Jun 15;378(2):259-68. (PMID: 10860543)
Biomed Pharmacother. 2022 Apr;148:112730. (PMID: 35183996)
Ann Hepatol. 2008 Apr-Jun;7(2):148-51. (PMID: 18626433)
J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):15-21. (PMID: 16706806)
Am J Med. 2007 Oct;120(10):829-34. (PMID: 17904449)
Liver Int. 2011 Sep;31(8):1137-43. (PMID: 21745286)
J Hepatol. 2015 Apr;62(1 Suppl):S47-64. (PMID: 25920090)
Q J Med. 1986 Oct;61(234):945-55. (PMID: 2819932)
Liver Int. 2016 Mar;36(3):317-24. (PMID: 26601627)
Ann Transl Med. 2017 Jul;5(13):270. (PMID: 28758096)
Biochim Biophys Acta. 2009 Nov;1787(11):1309-16. (PMID: 19413950)
BMJ. 2005 Jun 4;330(7503):1304-5. (PMID: 15849206)
Diabetes Res Clin Pract. 2011 Dec;94(3):311-21. (PMID: 22079683)
Redox Biol. 2013 Jan 21;1:145-52. (PMID: 24024147)
Mol Metab. 2017 May 31;6(9):1040-1051. (PMID: 28951827)
Gut. 2005 Apr;54(4):533-9. (PMID: 15753540)
Cancers (Basel). 2021 Aug 16;13(16):. (PMID: 34439277)
Cancer. 2010 Apr 15;116(8):1938-46. (PMID: 20166205)
Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1095-105. (PMID: 15489566)
Diabetes Care. 2014 Sep;37(9):2522-32. (PMID: 24898303)
Clin Ter. 2017 Jan-Feb;168(1):e37-e41. (PMID: 28240761)
Gastroenterology. 1999 Jun;116(6):1413-9. (PMID: 10348825)
Mol Cells. 2013 Oct;36(4):279-87. (PMID: 23794020)
J Transl Med. 2019 Aug 28;17(1):292. (PMID: 31462268)
Trends Biochem Sci. 2000 May;25(5):215-21. (PMID: 10782088)
ESMO Open. 2017 May 2;2(2):e000132. (PMID: 28761738)
Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2357-62. (PMID: 18006924)
J Cell Biol. 2016 Feb 15;212(4):379-87. (PMID: 26858267)
Nature. 2001 Dec 13;414(6865):807-12. (PMID: 11742413)
Hepatology. 2003 Mar;37(3):544-50. (PMID: 12601351)
Dig Liver Dis. 2015 Dec;47(12):997-1006. (PMID: 26454786)
Pathophysiology. 2008 Aug;15(2):91-101. (PMID: 18602801)
Phytomedicine. 2022 Jan;95:153797. (PMID: 34802869)
Nat Genet. 2015 May;47(5):505-511. (PMID: 25822088)
Liver Int. 2010 May;30(5):750-8. (PMID: 20331505)
Nat Genet. 2008 Dec;40(12):1461-5. (PMID: 18820647)
Diabetologia. 2007 Jan;50(1):74-83. (PMID: 17093947)
Am J Gastroenterol. 2013 Jun;108(6):881-91; quiz 892. (PMID: 23381014)
Diabetes Obes Metab. 2020 Dec;22(12):2408-2416. (PMID: 32761721)
Diabetologia. 2012 Apr;55(4):948-58. (PMID: 22120574)
World J Gastroenterol. 2014 Sep 28;20(36):12945-55. (PMID: 25278690)
Biomedicines. 2021 Oct 09;9(10):. (PMID: 34680546)
Biol Cell. 2013 May;105(5):219-233. (PMID: 23398201)
CA Cancer J Clin. 2015 Mar;65(2):87-108. (PMID: 25651787)
Sci STKE. 2000 Oct 10;2000(53):pe1. (PMID: 11752613)
J Gastroenterol. 2009;44(12):1190-4. (PMID: 19672551)
World J Gastroenterol. 2015 Apr 14;21(14):4103-10. (PMID: 25892859)
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):656-65. (PMID: 24080776)
Nature. 2013 Jul 4;499(7456):97-101. (PMID: 23803760)
CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593)
Hepatol Res. 2008 Nov;38 Suppl 1:S93-S101. (PMID: 19125960)
Diabetes Care. 2003 Apr;26(4):1047-51. (PMID: 12663571)
Carcinogenesis. 2002 Nov;23(11):1781-9. (PMID: 12419825)
Arch Pathol Lab Med. 2008 Nov;132(11):1761-6. (PMID: 18976012)
J Inflamm Res. 2021 Dec 09;14:6749-6764. (PMID: 34916823)
Cancers (Basel). 2021 Jul 30;13(15):. (PMID: 34359748)
Diabetes Care. 2016 Nov;39(11):1987-1995. (PMID: 27493134)
Diabetes Res Clin Pract. 2015 Dec;110(3):241-9. (PMID: 26520567)
Hepatology. 2012 Jun;55(6):1809-19. (PMID: 22183968)
Asian Pac J Cancer Prev. ;18(4):863-872. (PMID: 28545181)
Mol Cancer. 2013 Aug 02;12:86. (PMID: 23915189)
Int J Cancer. 2013 Feb 1;132(3):645-57. (PMID: 22618881)
CA Cancer J Clin. 2010 Jul-Aug;60(4):207-21. (PMID: 20554718)
J Clin Endocrinol Metab. 2015 Jun;100(6):2231-8. (PMID: 25885947)
J Hepatol. 2012 Mar;56(3):704-13. (PMID: 22120206)
فهرسة مساهمة: Keywords: cirrhosis; cytokines; diabetes mellitus; liver cancer; prognosis; steatohepatitis
تواريخ الأحداث: Date Created: 20221219 Date Completed: 20221220 Latest Revision: 20230118
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9772979
DOI: 10.1177/15330338221119743
PMID: 36533882
قاعدة البيانات: MEDLINE
الوصف
تدمد:1533-0338
DOI:10.1177/15330338221119743